Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
about
Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.Identifying "ownership" through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome.Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.Improving attendance to genetic counselling services for gynaecological oncology patients.Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
P2860
Q30587310-42EF588C-0D1D-4414-AAEA-DE7C6C96137DQ34017044-B4097B19-86F2-4884-AC4B-A82ADAB0CF40Q36030785-20C620D9-CAE8-45F6-97AD-CD4846B728FEQ36157315-35E2819F-90D3-4FCF-BC9C-4840DCB36670Q36171056-AE51FB91-BA61-4853-846B-B9D9990FFD50Q37125051-4B95A4F3-0F8F-4A14-BE2D-9429ACE0A094Q38805005-80831201-E894-469A-86BE-C7B3D4C76FFEQ40198462-469B3D03-7FB5-49C0-8852-70FC99B19BCCQ40250643-95F28452-ED11-4948-8833-1751068A1DEDQ47625453-7365C573-4CEA-4A34-B6AD-6F94B7B3C0BDQ48317493-330E6848-FFB7-4F1E-B87A-B1F70140D284Q48653777-0F3D720F-A228-42A5-8925-3EE04C58B354Q49199363-C2DD94E1-AAF9-4DC9-95E4-54B1A8157FCDQ50873130-42FD0255-7B25-45E9-A480-0ECE11B5B11EQ53519387-52405D86-C759-4393-A2CD-7B97E47D08E0
P2860
Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Underutilization of Lynch synd ...... tients with colorectal cancer.
@en
Underutilization of Lynch synd ...... tients with colorectal cancer.
@nl
type
label
Underutilization of Lynch synd ...... tients with colorectal cancer.
@en
Underutilization of Lynch synd ...... tients with colorectal cancer.
@nl
prefLabel
Underutilization of Lynch synd ...... tients with colorectal cancer.
@en
Underutilization of Lynch synd ...... tients with colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Underutilization of Lynch synd ...... tients with colorectal cancer.
@en
P2093
Adedayo A Onitilo
Alanna Kulchak Rahm
Andrew E Williams
Anh Quynh Le
CERGEN study team
Deanna S Cross
Gwen Alexander
Jennifer Webster
Katrina A B Goddard
Pamala A Pawloski
P2860
P2888
P304
P356
10.1038/GIM.2013.43
P407
P577
2013-05-02T00:00:00Z